ZOTAPharmaceuticals
Zota Health Care Limited — Profit & Loss Statement
₹1064.80
+0.00%
Zota Health Care Limited Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.16 Cr | 0.00 | — |
| Tax Rate For Calcs | 0.02 | 0.11 | 0.30 | 0.28 | — |
| Normalized EBITDA | -3.66 Cr | 8.71 Cr | 9.21 Cr | 16.36 Cr | — |
| Total Unusual Items | 0.00 | 0.00 | 0.54 Cr | 0.00 | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | 0.54 Cr | 0.00 | — |
| Net Income From Continuing Operation Net Minority Interest | -56.40 Cr | -14.35 Cr | -5.77 Cr | 8.91 Cr | — |
| Reconciled Depreciation | 43.20 Cr | 20.09 Cr | 11.96 Cr | 3.67 Cr | — |
| Reconciled Cost Of Revenue | 137.30 Cr | 96.70 Cr | 84.83 Cr | 89.31 Cr | — |
| EBITDA | -3.66 Cr | 8.71 Cr | 9.75 Cr | 16.36 Cr | — |
| EBIT | -46.86 Cr | -11.37 Cr | -2.21 Cr | 12.69 Cr | — |
| Net Interest Income | -10.78 Cr | -4.79 Cr | -1.68 Cr | 1.00 Cr | — |
| Interest Expense | 10.78 Cr | 4.79 Cr | 2.49 Cr | 0.26 Cr | — |
| Normalized Income | -56.40 Cr | -14.35 Cr | -6.15 Cr | 8.91 Cr | — |
| Net Income From Continuing And Discontinued Operation | -56.40 Cr | -14.35 Cr | -5.77 Cr | 8.91 Cr | — |
| Total Expenses | 341.90 Cr | 193.02 Cr | 143.78 Cr | 119.99 Cr | — |
| Diluted Average Shares | 2.73 Cr | 2.57 Cr | 2.52 Cr | 2.49 Cr | — |
| Basic Average Shares | 2.73 Cr | 2.57 Cr | 2.52 Cr | 2.49 Cr | — |
| Diluted EPS | -20.68 | -5.59 | -2.29 | 3.58 | — |
| Basic EPS | -20.68 | -5.59 | -2.29 | 3.58 | — |
| Diluted NI Availto Com Stockholders | -56.40 Cr | -14.35 Cr | -5.77 Cr | 8.91 Cr | — |
| Net Income Common Stockholders | -56.40 Cr | -14.35 Cr | -5.77 Cr | 8.91 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | -56.40 Cr | -14.35 Cr | -5.77 Cr | 8.91 Cr | — |
| Minority Interests | 0.34 Cr | 0.00 | 0.00 | 0.00 | — |
| Net Income Including Noncontrolling Interests | -56.74 Cr | -14.35 Cr | -5.77 Cr | 8.91 Cr | — |
| Net Income Continuous Operations | -56.74 Cr | -14.35 Cr | -5.77 Cr | 8.91 Cr | — |
| Tax Provision | -0.91 Cr | -1.81 Cr | 1.08 Cr | 3.53 Cr | — |
| Pretax Income | -57.64 Cr | -16.16 Cr | -4.69 Cr | 12.43 Cr | — |
| Other Non Operating Income Expenses | 2.07 Cr | 1.16 Cr | 0.04 Cr | 77000.00 | — |
| Special Income Charges | 0.00 | 0.00 | 0.54 Cr | 0.00 | — |
| Net Non Operating Interest Income Expense | -10.78 Cr | -4.79 Cr | -1.68 Cr | 1.00 Cr | — |
| Interest Expense Non Operating | 10.78 Cr | 4.79 Cr | 2.49 Cr | 0.26 Cr | — |
| Operating Income | -48.93 Cr | -12.53 Cr | -3.83 Cr | 11.20 Cr | — |
| Operating Expense | 204.60 Cr | 96.32 Cr | 58.95 Cr | 30.68 Cr | — |
| Other Operating Expenses | 75.34 Cr | 45.78 Cr | 0.33 Cr | 0.20 Cr | — |
| Depreciation And Amortization In Income Statement | 43.20 Cr | 20.09 Cr | 11.96 Cr | 3.67 Cr | — |
| Depreciation Income Statement | 43.20 Cr | 20.09 Cr | 10.45 Cr | 1.79 Cr | — |
| Gross Profit | 155.67 Cr | 83.79 Cr | 55.13 Cr | 41.89 Cr | — |
| Cost Of Revenue | 137.30 Cr | 96.70 Cr | 84.83 Cr | 89.31 Cr | — |
| Total Revenue | 292.97 Cr | 180.49 Cr | 139.96 Cr | 131.19 Cr | — |
| Operating Revenue | 292.97 Cr | 180.49 Cr | 139.96 Cr | 131.19 Cr | — |
| Write Off | — | 33000.00 | 0.00 | — | — |
| Interest Income | — | 0.95 Cr | 0.88 Cr | 1.32 Cr | 0.72 Cr |
| Rent Expense Supplemental | — | 0.50 Cr | 0.46 Cr | 0.69 Cr | 0.77 Cr |
| Net Income Discontinuous Operations | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Other Finance Cost | — | 0.59 Cr | 0.08 Cr | 0.06 Cr | 0.06 Cr |
| Interest Income Non Operating | — | 0.95 Cr | 0.88 Cr | 1.32 Cr | 0.72 Cr |
| Amortization | — | 1.36 Cr | 1.51 Cr | 1.88 Cr | — |
| Selling General And Administration | — | 41.28 Cr | 34.09 Cr | 15.96 Cr | 20.18 Cr |
| Selling And Marketing Expense | — | 13.22 Cr | 13.93 Cr | 7.84 Cr | 13.32 Cr |
| General And Administrative Expense | — | 28.06 Cr | 20.15 Cr | 8.12 Cr | 6.87 Cr |
| Rent And Landing Fees | — | 0.50 Cr | 0.46 Cr | 0.69 Cr | 0.77 Cr |
| Other Special Charges | — | — | -0.54 Cr | — | -1.03 Cr |
| Research And Development | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Zota Health Care Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.